GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vistin Pharma ASA (OSTO:VISTINo) » Definitions » Scaled Net Operating Assets

Vistin Pharma ASA (OSTO:VISTINO) Scaled Net Operating Assets : 0.76 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Vistin Pharma ASA Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Vistin Pharma ASA's operating assets for the quarter that ended in Dec. 2024 was kr372.2 Mil. Vistin Pharma ASA's operating liabilities for the quarter that ended in Dec. 2024 was kr75.4 Mil. Vistin Pharma ASA's Total Assets for the quarter that ended in Sep. 2024 was kr387.9 Mil. Therefore, Vistin Pharma ASA's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.76.


Vistin Pharma ASA Scaled Net Operating Assets Historical Data

The historical data trend for Vistin Pharma ASA's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vistin Pharma ASA Scaled Net Operating Assets Chart

Vistin Pharma ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.39 0.75 0.96 0.73 0.74

Vistin Pharma ASA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.78 0.82 0.78 0.77

Competitive Comparison of Vistin Pharma ASA's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Vistin Pharma ASA's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vistin Pharma ASA's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vistin Pharma ASA's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Vistin Pharma ASA's Scaled Net Operating Assets falls into.


;
;

Vistin Pharma ASA Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Vistin Pharma ASA's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(372.151-75.409)/403.396
=0.74

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=384.945 - 12.794
=372.151

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=75.409 - 0 - 0
=75.409

Vistin Pharma ASA's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Sep. 2024 )
=(372.151-75.409)/387.944
=0.76

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=384.945 - 12.794
=372.151

Operating Liabilities(Q: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=75.409 - 0 - 0
=75.409

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vistin Pharma ASA Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Vistin Pharma ASA's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Vistin Pharma ASA Business Description

Traded in Other Exchanges
Address
Ostensjoveien 27, P.O. Box 6735 Etterstad, Oslo, NOR, 0661
Vistin Pharma ASA is a Norway based pharmaceutical company. It is principally engaged in the business activity of producing active pharmaceutical ingredients (APIs) and solid dosage forms for the pharmaceutical industry. The company has two business segments namely Pharmaceuticals and Energy Trading. The group has operations in Norway, Germany, Switzerland, Great Britain, Algeria and other countries.

Vistin Pharma ASA Headlines

No Headlines